Trial intelligence / Profile preview

MACI vs microfracture in pediatric patients with knee cartilage defects

NCT03588975Phase 3Recruiting

Sponsor
Vericel
Start
Oct 2018
Primary completion
Feb 2030
Countries
1
01

Overview

A Phase 3 trial of autologous cultured chondrocytes on porcine collagen membrane in Articular cartilage defect, osteochondritis dissecans (OCD), sponsored by Vericel. Started Oct 2018; status: recruiting.

02

Drugs

autologous cultured chondrocytes on porcine collagen membrane
03

Conditions

Articular cartilage defectosteochondritis dissecans (OCD)

Beyond the preview

Go deeper on NCT03588975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03588975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call